Published in Glob Heart on March 26, 2015
Assessment of Global Kidney Health Care Status. JAMA (2017) 2.04
The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy). J Am Coll Cardiol (2013) 4.58
Addressing geographical variation in the progression of non-communicable diseases in Peru: the CRONICAS cohort study protocol. BMJ Open (2012) 1.52
Effectiveness of an mHealth intervention to improve the cardiometabolic profile of people with prehypertension in low-resource urban settings in Latin America: a randomised controlled trial. Lancet Diabetes Endocrinol (2015) 1.41
The World Heart Federation's vision for worldwide cardiovascular disease prevention. Lancet (2015) 0.96
Association of handgrip strength to cardiovascular mortality in pre-diabetic and diabetic patients: a subanalysis of the ORIGIN trial. Int J Cardiol (2014) 0.93
Polypills: essential medicines for cardiovascular disease secondary prevention? J Am Coll Cardiol (2014) 0.91
Dabigatran etexilate and reduction in serum apolipoprotein B. Heart (2015) 0.83
Low correlation between household carbon monoxide and particulate matter concentrations from biomass-related pollution in three resource-poor settings. Environ Res (2015) 0.82
Global cardiovascular research training for implementation science, health systems research, and health policy research. J Am Coll Cardiol (2015) 0.81
Reducing Premature Cardiovascular Mortality By 2025: The World Heart Federation Roadmap. Glob Heart (2015) 0.78
Adapting the World Heart Federation Roadmaps at the National Level: Next Steps and Conclusions. Glob Heart (2015) 0.77
Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial. Int J Cardiol (2015) 0.77
Patterns and Determinants of Physical Inactivity in Rural and Urban Areas in Peru: A Population-Based Study. J Phys Act Health (2016) 0.77
Reducing Premature Cardiovascular Morbidity and Mortality in People With Atherosclerotic Vascular Disease: The World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease. Glob Heart (2015) 0.77
Wealth and cardiovascular health: a cross-sectional study of wealth-related inequalities in the awareness, treatment and control of hypertension in high-, middle- and low-income countries. Int J Equity Health (2016) 0.75
Non-communicable disease alliance moving forward: follow-up to the United nations high-level meeting. Glob Heart (2012) 0.75
Impact of a Genetic Risk Score on Myocardial Infarction Risk Across Different Ethnic Populations. Can J Cardiol (2016) 0.75
World Heart Federation Cholesterol Roadmap. Glob Heart (2017) 0.75
Diet and Major Renal Outcomes: A Prospective Cohort Study. The NIH-AARP Diet and Health Study. J Ren Nutr (2016) 0.75
The Road to 25×25: Update on WHF CVD Roadmaps. Glob Heart (2016) 0.75
Associations of Urban Environment Features with Hypertension and Blood Pressure across 230 Latin American Cities. Environ Health Perspect (2022) 0.75
Secondary CV Prevention in South America in a Community Setting: The PURE Study. Glob Heart (2016) 0.75
Disparities in dietary intake and physical activity patterns across the urbanization divide in the Peruvian Andes. Int J Behav Nutr Phys Act (2017) 0.75
Cardiovascular Diseases on the Global Agenda: The United Nations High Level Meeting, Sustainable Development Goals, and the Way Forward. Glob Heart (2016) 0.75
Choosing exercise or pharmacologic stress imaging, or exercise ECG testing alone: How to decide. J Nucl Cardiol (2016) 0.75
A Pivotal Moment for Global Cardiovascular Disease The World Heart Federation and the UN NCD Summit. Glob Heart (2011) 0.75